President Donald Trump announced Wednesday that Dr. Heidi Overton, a physician and deputy director of the White House Domestic Policy Council, will be the administration’s nominee for commissioner of the Food and Drug Administration (FDA). Overton, who has worked on several of the president’s second‑term health initiatives, is described by the White House as a “smart and respected rockstar” who will advance the administration’s priorities for faster cures, greater innovation, lower drug prices and the Make America Healthy Again agenda.
Professional background
Dr. Overton earned her medical degree from the University of New Mexico and holds a doctorate in clinical investigation from Johns Hopkins University. Before joining the Trump administration, she served as chief policy officer at the America First Policy Institute, a conservative think tank focused on health‑policy reform.
Policy focus and recent activities
In recent months Overton has appeared alongside the president to promote a series of high‑profile health projects. These include negotiated “most favored nation” agreements with pharmaceutical companies intended to bring U.S. drug prices in line with those of other developed nations, and a controversial order to separate the combined measles‑mumps‑rubella (MMR) vaccine into three individual shots—a move that ran counter to the recommendations of major medical societies.
During an Oval Office event promoting the vaccine order, Overton stood beside the president as he suggested, without scientific support, that the timing or number of vaccines might be linked to rising rates of autism spectrum disorder. The claim contradicts decades of research confirming no causal relationship.
Potential impact on reproductive‑health regulations
Overton has expressed criticism of medication‑induced abortions. If confirmed, she would oversee the FDA’s regulatory framework for these drugs, potentially rolling back rules that expanded access to them. Pro‑life advocates have voiced frustration that the administration has not yet taken stronger steps to curb the distribution of abortion pills prescribed online, a development they say undermines state bans on abortions.
Confirmation outlook
The nominee will face a confirmation vote in a Senate that remains narrowly controlled by Republicans. Senate Health Committee Chairman Sen. Bill Cassidy, a Republican, has publicly criticized some of the president’s statements questioning vaccine safety, suggesting that Overton’s hearing could include rigorous questioning on those topics.
Should Overton be confirmed, the FDA would once again be led by a figure closely aligned with the president’s health agenda, navigating the competing pressures of the administration’s priorities, traditional Republican calls for deregulation, and the anti‑corporate stance of Health Secretary Robert F. Kennedy Jr.
Original reporting: 2news.com — read the source article.
